Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)
NCT05757544
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
for business reasons
Conditions
Status Epilepticus
Interventions
DRUG:
IV Ganaxolone
DRUG:
IV Placebo
Sponsor
Marinus Pharmaceuticals